{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:30Z","timestamp":1707524490803},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,30]]},"DOI":"10.7759\/cureus.23641","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:00:47Z","timestamp":1648634447000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuromyelitis Optica Spectrum Disorder: A Rare Cause of Spinal Cord and Optic Nerve Involvement"],"prefix":"10.7759","author":[{"given":"Steven","family":"Douedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Pilarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Al Kallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraaj S","family":"Pannu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Odak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Kozlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Elmedani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islam","family":"Elkherpitawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12271","article-title":"Neuromyelitis optica: clinical features, immunopathogenesis and treatment","volume":"176","author":"Jarius S","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014, 176:149-64. 10.1111\/cei.12271","journal-title":"Clin Exp Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.045","article-title":"Neuromyelitis optica: effect of gender","volume":"286","author":"Wingerchuk DM","year":"2009","unstructured":"Wingerchuk DM. Neuromyelitis optica: effect of gender. J Neurol Sci. 2009, 286:18-23. 10.1016\/j.jns.2009.08.045","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda S","year":"2019","unstructured":"Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Neuromyelitis optica spectrum disorders. Clin Med (Lond). 2019, 19:169-76. 10.7861\/clinmedicine.19-2-169","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius S","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, et al.. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008, 4:202-14. 10.1038\/ncpneuro0764","journal-title":"Nat Clin Pract Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius S","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, et al.. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011, 306:82-90. 10.1016\/j.jns.2011.03.038","journal-title":"J Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock SJ","year":"2006","unstructured":"Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006, 63:964-8. 10.1001\/archneur.63.7.964","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.249","article-title":"Brain involvement in neuromyelitis optica spectrum disorders","volume":"68","author":"Chan KH","year":"2011","unstructured":"Chan KH, Tse CT, Chung CP, Lee RL, Kwan JS, Ho PW, Ho JW. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol. 2011, 68:1432-9. 10.1001\/archneurol.2011.249","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.34","article-title":"Beneficial plasma exchange response in central nervous system inflammatory demyelination","volume":"68","author":"Maga\u00f1a SM","year":"2011","unstructured":"Maga\u00f1a SM, Keegan BM, Weinshenker BG, et al.. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011, 68:870-8. 10.1001\/archneurol.2011.34","journal-title":"Arch Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513495938","article-title":"Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients","volume":"20","author":"Elsone L","year":"2014","unstructured":"Elsone L, Panicker J, Mutch K, Boggild M, Appleton R, Jacob A. Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients. Mult Scler. 2014, 20:501-4. 10.1177\/1352458513495938","journal-title":"Mult Scler"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511404586","article-title":"Impact of rituximab on relapse rate and disability in neuromyelitis optica","volume":"17","author":"Bedi GS","year":"2011","unstructured":"Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult Scler. 2011, 17:1225-30. 10.1177\/1352458511404586","journal-title":"Mult Scler"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler RN","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998, 51:1219-20. 10.1212\/wnl.51.4.1219","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92648-neuromyelitis-optica-spectrum-disorder-a-rare-cause-of-spinal-cord-and-optic-nerve-involvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:14Z","timestamp":1707507374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92648-neuromyelitis-optica-spectrum-disorder-a-rare-cause-of-spinal-cord-and-optic-nerve-involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.23641","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,30]]}}}